Noninvasive testing are poor surrogate markers for fibrosis staging and liver-related outcomes in patients with primary biliary cirrhosis who do not respond to ursodeoxycholic acid
HEPATOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HEPATOLOGY(2014)